Latham & Watkins has advised Crystalys Therapeutics. Wilson Sonsini Goodrich & Rosati has advised Novo Holdings and SR One. Crystalys Therapeutics Inc., a clinical-stage biopharmaceutical company,...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Airbus on the deal. Stratify Aerospace, LLC (Stratify) announced the acquisition of Metron Aviation, Inc. (Metron Aviation) from Airbus. Stratify Aerospace is a...
You must be a Standard 1 Year member to access this content.
Norton Rose Fulbright represented Alcon Inc., Latham & Watkins represented LENSAR, Inc. in the transaction. Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Keymed Biosciences on the deal. Keymed Biosciences (HKSe: 02162) signed a licensing agreement granting Platina the exclusive worldwide rights to develop, manufacture and...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Keymed Biosciences on the deal. Timberlyne Therapeutics, Inc. announced its US$180 million Series A financing to advance the development of CM313. Investors Abingworth,...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Charme Capital Partners on the deal. Charme Capital Partners, a pan-European private equity firm, announced the acquisition of Centogene GmbH, a rare diseases...
You must be a Standard 1 Year member to access this content.
Legance, Linklaters, King & Spalding, EY SLT and Machado, Meyer, Sendacz e Opice advised Almaviva, while Latham & Watkins advised Iteris. PedersoliGattai, Milbank and TozziniFreire advised...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, McDermott Will & Emery, and Mason Hayes & Curran advised LetsGetChecked, while Latham & Watkins and BakerHostetler advised Truepill on the deal. LetsGetChecked, a...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Viking Global Investors on the deal. Viking Global Investors (Viking), a global investment firm based in the United States, acquired a significant minority...
You must be a Standard 1 Year member to access this content.
Latham & Watkins acted for Iteris; King & Spalding, Legance and Linklaters advised Almaviva. The Italian group Almaviva S.p.A. has acquired Iteris, a company listed on...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Spectris Plc on the deal. Spectris plc (SXS: LSE), the expert in providing insight through precision measurement, has agreed to acquire SciAps Incorporated...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Haier Group on the global regulatory filings. Haier Group has completed its RMB12.5 billion (approximately US$1.8 billion) acquisition of a 20% equity...
You must be a Standard 1 Year member to access this content.
